A Pilot Trial of Triheptanoin for People with Amyotrophic Lateral Sclerosis (PALS)

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Stanley Bedlack Neurology, Neuromuscular Disease

Administered By

Neurology

Awarded By

Ultragenyx Pharmaceutical

Start Date

April 20, 2018

End Date

May 22, 2020

Administered By

Neurology

Awarded By

Ultragenyx Pharmaceutical

Start Date

April 20, 2018

End Date

May 22, 2020